{"id":"lotrel-amlodipine-benazepril","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Headache"},{"rate":"10-15","effect":"Dizziness"},{"rate":"5-10","effect":"Fatigue"},{"rate":"5-10","effect":"Peripheral edema"},{"rate":"5-10","effect":"Cough"},{"rate":"2-5","effect":"Palpitations"}]},"_chembl":{"chemblId":"CHEMBL1200402","moleculeType":"Small molecule","molecularWeight":"567.06"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amlodipine blocks L-type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral resistance. Benazepril inhibits angiotensin-converting enzyme (ACE), preventing conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and aldosterone secretion. Together, these mechanisms provide additive antihypertensive effects.","oneSentence":"Lotrel combines a calcium channel blocker and an ACE inhibitor to lower blood pressure through two complementary pathways: relaxing blood vessel smooth muscle and reducing angiotensin II-mediated vasoconstriction.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:06.947Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT07486453","phase":"PHASE1","title":"Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2026-03-09","conditions":"Primary Hypertension","enrollment":60},{"nctId":"NCT00834977","phase":"PHASE1","title":"Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-04","conditions":"Healthy","enrollment":48},{"nctId":"NCT00835367","phase":"PHASE1","title":"Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-03","conditions":"Healthy","enrollment":68},{"nctId":"NCT00649519","phase":"PHASE1","title":"Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-05","conditions":"Healthy","enrollment":54},{"nctId":"NCT00649402","phase":"PHASE1","title":"Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2004-05","conditions":"Healhty","enrollment":64},{"nctId":"NCT00170950","phase":"PHASE3","title":"Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension","status":"TERMINATED","sponsor":"Novartis","startDate":"2003-10","conditions":"Hypertension","enrollment":11506},{"nctId":"NCT00139555","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Hypertension, Left Ventricular Hypertrophy","enrollment":125},{"nctId":"NCT00000620","phase":"PHASE3","title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1999-09","conditions":"Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia","enrollment":10251},{"nctId":"NCT00171366","phase":"PHASE3","title":"A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Hypertension","enrollment":1422},{"nctId":"NCT01603940","phase":"PHASE4","title":"Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2012-05","conditions":"Hypertension, Diabetes Mellitus","enrollment":30},{"nctId":"NCT01505998","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-03","conditions":"Fed","enrollment":49},{"nctId":"NCT01506011","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2007-03","conditions":"Fasting","enrollment":50},{"nctId":"NCT00136851","phase":"PHASE4","title":"Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2004-12","conditions":"Hypertension","enrollment":259},{"nctId":"NCT00367978","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novartis","startDate":"2001-12","conditions":"Hypertension","enrollment":275},{"nctId":"NCT01375322","phase":"PHASE4","title":"ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria","status":"COMPLETED","sponsor":"TSH Biopharm Corporation Limited","startDate":"2007-06","conditions":"Hypertension, Diabetes Mellitus, Type 2, Albuminuria","enrollment":226},{"nctId":"NCT00136773","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-04","conditions":"Albuminuria","enrollment":332},{"nctId":"NCT01155908","phase":"PHASE1","title":"Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-04","conditions":"Healthy","enrollment":48},{"nctId":"NCT01155895","phase":"PHASE1","title":"Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2004-03","conditions":"Healthy","enrollment":54},{"nctId":"NCT00234871","phase":"PHASE4","title":"Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-01","conditions":"Hypertension, Diabetes, Proteinuria","enrollment":357}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Lotrel (amlodipine/benazepril)","genericName":"Lotrel (amlodipine/benazepril)","companyName":"Abbott","companyId":"abbott","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lotrel combines a calcium channel blocker and an ACE inhibitor to lower blood pressure through two complementary pathways: relaxing blood vessel smooth muscle and reducing angiotensin II-mediated vasoconstriction. Used for Hypertension, Angina pectoris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}